Jones Day | USA | 27 Dec 2017
In 2016, the PTAB changed the limits for the length of certain filings in post grant proceedings, including petitions and responses, from limits…
Wolf, Greenfield & Sacks, PC | USA | 27 Sep 2017
The 2015 decision of the U.S. Court of Appeals for the Federal Circuit in Akamai Techs., Inc. v. Limelight Networks, Inc., 797 F.3d 1020, 116 U.S.P.Q…
Haug Partners LLP | USA | 30 Mar 2017
On January 12, 2017, the Federal Circuit decided Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., providing its first opinion on divided…
Foley & Lardner LLP | USA | 24 Jan 2017
In Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., the Federal Circuit affirmed the district court decision finding infringement under Akami of a…
McDermott Will & Emery | USA | 30 May 2016
In an opinion addressing divided infringement in view of the Supreme Court of the United States’ 2014 decision in Limelight Networks v. Akamai…
Proskauer Rose LLP | USA | 25 May 2016
In a lengthy litigation between Akamai Technologies, Inc. ("Akamai") and Limelight Networks, Inc. ("Limelight"), the District of Massachusetts…
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 10 May 2016
In Mankes v. Vivid Seats Ltd., the Federal Circuit considered a change in the law of divided patent infringement resulting from the Akami-Limelight…
Fish & Richardson | USA | 2 May 2016
On Monday the Supreme Court denied certiorari in Limelight Networks Inc. v. Akamai Technologies Inc. et al, Case No. 15-993. Limelight had petitioned…
Manatt Phelps & Phillips LLP | USA | 19 Apr 2016
Limelight Networks, Inc. filed a petition for a writ of certiorari with the U.S. Supreme Court, asking it to review the Federal Circuit's en banc…
Oblon | USA | 7 Apr 2016
Over the past week, amicus briefs supporting the respondent (U.S. Gov't) have been filed with the Supreme Court in Cuozzo Speed v. Lee. These…